Oncoclínicas cancels November 3 shareholder meeting following Josephina III request
Bitget2026/10/29 00:22- Oncoclínicas canceled its November 3, 2026, extraordinary shareholder meeting following a cancellation request from shareholder Josephina III.
- An October 23 court ruling provisionally suspended a CVM decision requiring a tender offer under Article 39 of its bylaws.
- Josephina III challenged the CVM decision in court; management determined the ruling left the shareholder-requested meeting without a purpose.
- Latache IV, Nova Almeida and Latache MHF I had requested the meeting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.